📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Drug Abuse Sciences

1.1 - Company Overview

Drug Abuse Sciences Logo

Drug Abuse Sciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapies for alcohol and drug addictions, offering Naltrexone Depot, a sustained-release formulation of naltrexone for alcohol and opiate addictions; DAS-431 for cocaine addiction; and Buprenorphine Depot, a sustained-release formulation.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Drug Abuse Sciences

Emboline Logo

Emboline

HQ: United States Website
  • Description: Provider of total embolic protection during percutaneous heart valve repair, offering the Emboliner Total Embolic Protection Catheter designed to capture and remove embolic debris to protect the brain and other organs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Emboline company profile →
AZ Therapies Logo

AZ Therapies

HQ: United States Website
  • Description: Provider of clinical-stage biotech R&D aimed at breakthrough treatments for neuroinflammation-related diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AZ Therapies company profile →
Aruna Bio Logo

Aruna Bio

HQ: United States Website
  • Description: Provider of neural exosome-based therapies for central nervous system and neurodegenerative disorders; developer of AB126, a therapeutic neural cell-derived exosome that crosses the blood-brain barrier to reduce neuro-inflammation, promote neuro-protection, and stimulate neuro-regeneration, plus a CNS therapeutic platform and pipeline; also conducts research in stem cells, neural stem cells, and drug toxicity assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aruna Bio company profile →
Chase Therapeutics Logo

Chase Therapeutics

HQ: United States Website
  • Description: Provider of early-stage, product-based specialty pharmaceuticals, including CTC-413 for symptomatic and neuroprotective treatment of Parkinson’s disease and related disorders (Phase 2), CTC-501 for symptomatic treatment of major depressive disorder (Phase 2), and a Parkinson’s disease bioassay for diagnosis and immediate-response outcome measurement in clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chase Therapeutics company profile →
Freespira Logo

Freespira

HQ: United States Website
  • Description: Provider of the only FDA-cleared, at-home, drug-free digital therapeutic proven to significantly reduce or eliminate panic attacks, panic disorder, and PTSD symptoms in 28 days. The Freespira treatment uses a sensor and tablet to normalize breathing. Also offers resources for health plans, employees, and individuals, a veterans relief program, and a provider referral program with insurance coverage information.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Freespira company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Drug Abuse Sciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Drug Abuse Sciences

2.2 - Growth funds investing in similar companies to Drug Abuse Sciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Drug Abuse Sciences

4.2 - Public trading comparable groups for Drug Abuse Sciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Drug Abuse Sciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Drug Abuse Sciences

What does Drug Abuse Sciences do?

Drug Abuse Sciences is a provider of therapies for alcohol and drug addictions, offering Naltrexone Depot, a sustained-release formulation of naltrexone for alcohol and opiate addictions; DAS-431 for cocaine addiction; and Buprenorphine Depot, a sustained-release formulation.

Who are Drug Abuse Sciences's competitors?

Drug Abuse Sciences's competitors and similar companies include Emboline, AZ Therapies, Aruna Bio, Chase Therapeutics, and Freespira.

Where is Drug Abuse Sciences headquartered?

Drug Abuse Sciences is headquartered in United States.

How many employees does Drug Abuse Sciences have?

Drug Abuse Sciences has 1,000 employees 🔒.

When was Drug Abuse Sciences founded?

Drug Abuse Sciences was founded in 2010 🔒.

What sector and industry vertical is Drug Abuse Sciences in?

Drug Abuse Sciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Drug Abuse Sciences

Who are the top strategic acquirers in Drug Abuse Sciences's sector and industry

Top strategic M&A buyers and acquirers in Drug Abuse Sciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Drug Abuse Sciences?

Top strategic M&A buyers groups and sectors for Drug Abuse Sciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Drug Abuse Sciences's sector and industry vertical

Which are the top PE firms investing in Drug Abuse Sciences's sector and industry vertical?

Top PE firms investing in Drug Abuse Sciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Drug Abuse Sciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Drug Abuse Sciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Drug Abuse Sciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Drug Abuse Sciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Drug Abuse Sciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Drug Abuse Sciences?

The key public trading comparables and valuation benchmarks for Drug Abuse Sciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Drug Abuse Sciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Drug Abuse Sciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Drug Abuse Sciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Drug Abuse Sciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Drug Abuse Sciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Drug Abuse Sciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Drug Abuse Sciences